Monday, 2 November 2026LatestVideosAboutContact
Latest
29 Pakistani players register for APL draft despite NOC being unlikely; here's the full list72% of students say they procrastinate. Here's how to stay on trackWhy birds speed up to slow down: The physics of landingAI must move beyond intelligence to offer wiser, ethical advice: Experts at IIT RoparMichael Carrick quizzed on Martinez, dressing room unity and his future at the pre-Roma press conferenceRapido’s Manasvi Mann Gets Representation On National Gig Workers' Welfare PanelChandra reappointment has sullied Tata Sons’ image: Darius Khambata; declines another term in officeTVS Holdings allotted shares in Home Credit India Finance as part of rights issueDr. Reddy’s secures U.S. FDA tentative nod for HIV drug lenacapavirOverdependence on fossil fuels will continue to disrupt global economy: PM ModiRanji Trophy 2026-27: Ton-up Pradosh still not satisfiedIndia vs New Zealand ODI Series: Full schedule, squads, live streaming – all you need to know
BusinessUpdated 1 hr ago

Dr Reddy’s injectable lenacapavir for HIV prevention gets tentative nod from USFDA

Image: BusinessLine

The first supplies are expected to reach people by the end of 2026, with broader rollout across eligible countries expected in 2027

Continue reading on BusinessLine

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all